April 30, 2025 - 05:11

At least some workers at NIOSH are getting back to work this week after federal cuts in early April took them off the job. These cuts have raised concerns about the impact on health screenings for coal miners in West Virginia, a state where the mining industry plays a crucial role in the economy and the health of its workers.
The National Institute for Occupational Safety and Health (NIOSH) has been integral in conducting health assessments and screenings for coal miners, focusing on conditions such as black lung disease. However, the recent budget reductions have led to a temporary halt in many of these essential services, prompting fears among miners and their families about the potential deterioration of their health monitoring.
As some NIOSH employees return, there is hope that screenings can resume, albeit on a limited basis. The community is closely watching how these developments will unfold, as the health of coal miners remains a pressing issue in West Virginia. The situation underscores the ongoing challenges faced by federal agencies in maintaining critical health services amid budget constraints.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...